[TNGX] YoY Quarter Result on 31-Mar-2022 [#Q1]

Stock
[TNGX] Tango Therapeutics, Inc.
Announcement Date
11-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- -13.57%
YoY- -106.81%
Quarter Report
TNGX's Result
TNGX's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 CAGR
Revenue 6,471 5,766 5,758 6,386 4,711 8.25%
PBT -37,874 -28,008 -25,208 -12,032 -7,914 47.86%
Tax 40 -2,278 -171 74 0 -
NP -37,914 -25,730 -25,037 -12,106 -7,914 47.90%
Tax Rate - - - - - -
Total Cost 44,385 31,496 30,795 18,492 12,625 36.90%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 CAGR
NP Margin -585.91 -446.24 -434.82 -189.57 -167.99 36.62%
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 CAGR
EPS -0.35 -0.29 -0.29 -0.14 -0.74 -17.05%
EPS Diluted -0.35 -0.29 -0.29 -0.14 -0.74 -17.05%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.